Company / Cash & Equivalents
MeiraGTx Holdings plc Cash & Equivalents History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$65.9M
FY2025
5-year range
$65.9M / $137.7M
FY2021-FY2025
Trend
-36.4%
vs FY2024
Sector context
#170 of 207
Health Care
What the data says
MeiraGTx Holdings plc's cash & equivalents of $66M is lower than 82% of companies in the Health Care sector (FY2025). Cash & Equivalents has fluctuated over the past 9 years, ranging from $9M in FY2017 to $227M in FY2019.
Based on SEC 10-K filings.
$66M in FY2025 with a 5-year CAGR of -20.6%.
Declined from $130M to $66M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -17.1%
- 5-Year CAGR
- -20.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 207This company $65.9M Sector average $669.5M
▼
-90.2% below sector average
Key checks
Key Insights
- 5-year CAGR of -20.6%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 36.4% year-over-year.
- Ranks #170 out of 207 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.88 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $65.9M | -36.4% |
| FY2024 | $103.7M | -20.0% |
| FY2023 | $129.6M | +12.2% |
| FY2022 | $115.5M | -16.1% |
| FY2021 | $137.7M | -34.3% |
| FY2020 | $209.5M | -7.8% |
| FY2019 | $227.2M | +233.8% |
| FY2018 | $68.1M | +696.4% |
| FY2017 | $8.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026